Wildcat Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ImmunityBio
IBRX
|
+$98.1M |
| 2 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
+$15.5M |
| 3 |
Hilton Worldwide
HLT
|
+$6.57M |
| 4 |
ADVM
Adverum Biotechnologies
ADVM
|
+$192K |
| 5 |
COOP
Mr. Cooper
COOP
|
+$123K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$9M |
| 2 |
LPL Financial
LPLA
|
+$7.14M |
| 3 |
StealthGas
GASS
|
+$6.36M |
| 4 |
CoStar Group
CSGP
|
+$2.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.96% |
| 2 | Real Estate | 17.05% |
| 3 | Consumer Discretionary | 3.47% |
| 4 | Financials | 3.1% |
| 5 | Communication Services | 0.3% |
Similar funds
Wildcat Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Wildcat Capital Management held 22 positions worth $268M, down 8.2% from $292M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Wildcat Capital Management deployed $102M of net new capital in Q3 2015, opening 7 new positions and adding to 2 existing holdings. Its largest new stake was ImmunityBio: 4,495,495 shares worth $51.5M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 2.4% a quarter earlier, followed by Real Estate and Consumer Discretionary.
On the sell side, the largest reduction was LPL Financial, an estimated $7.14M trimmed.
- Wildcat Capital Management's largest Q3 2015 buy was ImmunityBio: 4,495,495 shares worth $51.5M.
- Wildcat Capital Management added most to Sorrento Therapeutics, Inc. in Q3 2015, an estimated $15.5M increase.
- Wildcat Capital Management's biggest Q3 2015 reduction was LPL Financial, cutting an estimated $7.14M.
- Wildcat Capital Management fully exited People Inc in Q3 2015, selling an estimated $9M.
- Wildcat Capital Management's ten largest holdings make up 99% of its $268M portfolio in Q3 2015.
- Wildcat Capital Management opened 7 new positions and closed 2 in Q3 2015.
- Wildcat Capital Management's portfolio value fell 8.2% quarter-over-quarter to $268M.
Based on Wildcat Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.